
Ep 124 Elevating Sales Outcomes through Rev Ops Excellence with Jess Rose
Mental Selling: The Sales Performance PodcastShow Notes
Revenue Operations is one of the most strategic drivers of growth, even if many organizations only notice it when something breaks. Jess Rose, the newly hired Director of Revenue Operations at Integrity Solutions, joins Mental Selling to emphasize a discipline that many organizations undervalue but rely on every single day. In her first weeks with the company, she is already bringing clarity to the systems, processes, and decisions that fuel predictable performance. Jess explains why Rev Ops is the connective tissue across sales, marketing, and customer success, and why clean data, transparent processes, and human-centered systems create the conditions for scalable growth. She shares lessons from her career leading operational strategy, including how minor workflow adjustments can create meaningful lift, why sellers need clarity rather than more noise, and how human habits can either strengthen or derail even the best-designed systems. Listeners will gain a grounded view of how Rev Ops strengthens alignment, improves decision-making, and creates the conditions for consistent, confident performance. In this episode, you’ll learn: Operational Excellence Starts with the Basics: Clean data, clear ownership, and simple enablement power confident, consistent performance. Process as a Growth Lever: Standardized stages and documented workflows create a shared path that drives predictable results. Technology That Works for People: Tools designed with a human-first lens remove friction and help reps stay focused on selling. Adoption Through Trust: Teams commit to operational change when the process feels supportive, transparent, and genuinely helpful.
Resources: Jess Rose’s LinkedIn: https://www.linkedin.com/in/jessica-rose-2b482122/ Learn more about Integrity Solutions: https://www.integritysolutions.com/
Jump into the conversation: (00:00) Meet Jess Rose (02:31) What revenue operations really means (04:42) Jess’s path into Rev Ops (06:39) Misconceptions that hold teams back (08:40) Why data hygiene influences revenue health (11:37) Simple fixes that create measurable impact to the bottom line (16:21) The human habits behind operational success (22:01) Building trust across sales, marketing, and customer success
More from Mental Selling: The Sales Performance Podcast
The biggest threat to a complex sale may be the hesitation your buyer never voices. In this second of a two-part series adapted from a webinar, Mike O’Brien, Executive Vice President of Sales at Integrity Solutions, and Tom Whelan, Ph.D., Director of Corporate Research at Training Industry, Inc., explore the final two breakdowns that can derail complex B2B sales: the fear of change and budget ambiguity. They explain why the status quo is often a seller’s biggest competitor, how unspoken concerns about disruption can quietly delay decisions, and why sellers need to make the path forward feel less risky for buyers. Mike and Tom also discuss why budget conversations need to happen earlier in discovery and how the right framing can turn an uncomfortable discussion about cost into a productive conversation about priorities and business value. They bring all five breakdowns from the series together, showing how stronger judgment, conversation skills, training, and coaching can help sellers create clarity and confidence throughout the buying process. In this episode, you’ll learn: Overcoming the Status Quo: How to uncover unspoken hesitation and make change feel less risky for buyers. Navigating Budget Conversations: Why sellers need to discuss investment priorities earlier in the sales process. Framing Tough Questions: How tone, sequencing, and language can make difficult conversations about budget feel more natural and productive. Connecting Budget to Business Value: Why buyers need a clear business case and stronger evidence of ROI before they feel confident moving forward. Coaching Complex Opportunities: How sales leaders can identify missing stakeholders, stalled momentum, and other warning signs during pipeline reviews.
Why do promising complex sales deals suddenly lose momentum and go nowhere? In this first of a two-part series adapted from a webinar, Mike O’Brien, Executive Vice President of Sales at Integrity Solutions, and Tom Whelan, Ph.D., Director of Corporate Research at Training Industry, Inc., examine the common breakdowns that cause promising sales opportunities to stall. They discuss why sellers can mistake a responsive, enthusiastic contact for someone with real decision making influence, and how that mistake can leave them restarting the sales process when the right stakeholders finally enter the conversation. Mike and Tom also explore why leading with product features can make even a polished sales conversation irrelevant to the buyer, and why sellers need to connect capabilities directly to business problems and desired outcomes. Finally, they unpack one of the quietest threats to a complex sale: losing momentum between meetings when next steps and commitments are unclear. In this episode, you’ll learn: Finding the Right Decision Makers: Why a responsive, enthusiastic contact may not have real influence, and how relying on one champion can stall a deal. Selling Outcomes Over Features: How connecting solutions to real business problems makes sales conversations more relevant to buyers. Maintaining Sales Momentum: Why clear next steps and consistent engagement keep complex deals from quietly stalling. Navigating Buyer Complexity: How internal alignment, procurement, and ROI questions can extend the buying process. Building the Right Sales Skills: Why sellers need deliberate practice to build the skills required to manage complex opportunities.
If AI is everywhere in sales, why are so many teams still missing quota? In this first of a two-part series adapted from a webinar, Amara Hunt, Chief Product Officer at Integrity Solutions with a career spent at the intersection of design, data, and strategy, explores the untapped gap sitting inside most AI adoption strategies. She explains why 81% of sales teams have adopted AI while 70% of reps are still missing quota, even when they already have the access, tools, and efficiency gains needed to move faster. Amara reframes AI as an amplifier rather than a methodology, showing how teams can either scale strong habits or accelerate weak ones depending on what they bring to it. She then breaks down the capability frontier, the line separating tasks AI reliably improves from the human judgment it can't replace, and shares a personal story that reveals the risk of over-relying on it: the illusion of competence.
Being in the room is only half the battle. Knowing how to ask the right questions is what turns that access into strategic influence. In the second part of this two-part series adapted from a webinar, Amanda Ervin, Senior Learning and Performance Consultant at Integrity Solutions, and Michelle Dillon, a healthcare industry veteran with more than 24 years of experience in sales, clinical, and training roles, dig into the practical layer of activating clinical teams as strategic partners. They explain why access to decision-makers has declined sharply, and why clinical specialists are often still the ones getting in the door. Amanda walks through a four-lane questioning framework that helps clinical specialists move from reactive support to genuine diagnostic partners, uncovering root causes instead of just fixing symptoms. Michelle closes with five concrete moves that clinical teams can use to build strategic influence, strengthen collaboration with sales, and turn trust into lasting influence.
Trust gets clinical specialists in the room. Strategic influence is what helps them create greater impact once they are there. In this first of a two-part series adapted from a webinar, Amanda Ervin, Senior Learning and Performance Consultant at Integrity Solutions, and Michelle Dillon, a healthcare industry veteran with more than 24 years of experience in sales, clinical, and training roles, explore the untapped potential sitting inside clinical teams.